AIP
ArterisBAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3AI sentiment snapshot
AI commentary
Sentiment improved materially after the May 12, 2026 earnings release: the company delivered a beat-and-raise quarter, analyst targets moved up on May 13-14, and the post-print move held into the May 14 close. That said, this is still a medium-coverage name with limited broad analyst depth, and the rally appears to have already absorbed much of the immediate positive revision signal rather than leaving a clearly underappreciated setup.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
On May 12, 2026 Arteris reported Q1 revenue of $22.9M, ACV plus royalties of $92.8M, RPO of $118.3M, and updated FY2026 revenue guidance to $91M-$95M from the prior $89M-$93M, with Q2 revenue guided to $23M-$24M; that is the clearest near-term support for the thesis, though much of the earnings surprise is now reflected in the move higher after the print. [#8-K-2026-05-12] [#10-Q-2026-05-12]
By May 13-14, 2026, checked secondary coverage showed Rosenblatt lifting its target to $38 from $20, TD Cowen to $40 from $22, Jefferies to $35 from $16, and Northland to $38 from $24; this confirms a delayed positive revision cycle, but it also leaves the stock trading near the updated target band rather than far below it.
Management tied Q1 demand to AI-enabled chips, hyperscaler expansion, HBM-related programs, automotive and aerospace demand, while the Cycuity acquisition adds semiconductor cybersecurity assurance capability; if those wins convert into sustained royalty and licensing growth, the earnings power can move higher, but proof still needs several quarters of execution. [#8-K-2026-05-12] [#10-Q-2026-05-12] [#10-K-2026-02-12]
Recommendation
No formal recommendation provided.

